| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.93T | 6.54T | 6.08T | 5.91T | 5.69T | 5.21T |
| Gross Profit | 3.34T | 3.16T | 2.93T | 2.72T | 2.80T | 2.50T |
| EBITDA | 1.84T | 1.74T | 1.64T | 1.75T | 1.73T | 1.66T |
| Net Income | 565.67B | 519.98B | 489.07B | 531.37B | 517.08B | 491.29B |
Balance Sheet | ||||||
| Total Assets | 18.24T | 16.10T | 15.52T | 14.68T | 13.10T | 12.21T |
| Cash, Cash Equivalents and Short-Term Investments | 1.58T | 1.61T | 2.15T | 2.19T | 1.66T | 1.67T |
| Total Debt | 7.26T | 5.96T | 6.32T | 6.13T | 6.02T | 5.59T |
| Total Liabilities | 13.75T | 11.84T | 11.59T | 11.00T | 9.88T | 9.47T |
| Stockholders Equity | 2.86T | 2.74T | 2.38T | 2.22T | 1.96T | 1.54T |
Cash Flow | ||||||
| Free Cash Flow | 538.47B | 621.21B | 685.62B | 546.53B | 506.83B | 859.43B |
| Operating Cash Flow | 1.25T | 1.37T | 1.24T | 1.16T | 1.22T | 1.34T |
| Investing Cash Flow | -1.20T | -971.93B | -893.40B | -123.87B | -950.57B | -504.12B |
| Financing Cash Flow | -368.09B | -979.68B | -391.30B | -526.17B | -312.19B | -395.64B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥317.70B | 18.43 | 13.42% | 2.27% | 5.10% | 12.48% | |
71 Outperform | ¥10.08T | 16.09 | 13.75% | 2.85% | 3.34% | 20.36% | |
62 Neutral | ¥3.10B | 5.37 | ― | ― | -3.76% | -67.98% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
60 Neutral | ¥10.31T | 19.08 | ― | 3.99% | 7.79% | 5.53% | |
60 Neutral | ¥430.11B | 19.63 | 15.67% | 1.31% | 12.48% | 18.38% | |
56 Neutral | ¥13.38T | 9.80 | 11.22% | 3.36% | 2.10% | -9.29% |